Tivic Health Systems Statistics
Total Valuation
TIVC has a market cap or net worth of $3.22 million. The enterprise value is -$2.94 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TIVC has 2.88 million shares outstanding. The number of shares has increased by 302.11% in one year.
| Current Share Class | 2.88M |
| Shares Outstanding | 2.88M |
| Shares Change (YoY) | +302.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.45% |
| Owned by Institutions (%) | 8.41% |
| Float | 2.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.13, with a Debt / Equity ratio of 0.38.
| Current Ratio | 20.13 |
| Quick Ratio | 19.57 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -54.10 |
Financial Efficiency
Return on equity (ROE) is -82.69% and return on invested capital (ROIC) is -38.29%.
| Return on Equity (ROE) | -82.69% |
| Return on Assets (ROA) | -28.69% |
| Return on Invested Capital (ROIC) | -38.29% |
| Return on Capital Employed (ROCE) | -25.51% |
| Weighted Average Cost of Capital (WACC) | 6.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$170,731 |
| Employee Count | 52 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.29% in the last 52 weeks. The beta is 1.84, so TIVC's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -84.29% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 2.13 |
| Relative Strength Index (RSI) | 56.26 |
| Average Volume (20 Days) | 68,140 |
Short Selling Information
The latest short interest is 93,186, so 3.24% of the outstanding shares have been sold short.
| Short Interest | 93,186 |
| Short Previous Month | 169,146 |
| Short % of Shares Out | 3.24% |
| Short % of Float | 3.70% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.90M |
| Pretax Income | -7.99M |
| Net Income | -8.88M |
| EBITDA | -7.89M |
| EBIT | -7.90M |
| Earnings Per Share (EPS) | -$7.68 |
Full Income StatementBalance Sheet
The company has $12.65 million in cash and $6.45 million in debt, with a net cash position of $6.19 million or $2.15 per share.
| Cash & Cash Equivalents | 12.65M |
| Total Debt | 6.45M |
| Net Cash | 6.19M |
| Net Cash Per Share | $2.15 |
| Equity (Book Value) | 16.80M |
| Book Value Per Share | 6.65 |
| Working Capital | 12.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.00 million and capital expenditures -$38,000, giving a free cash flow of -$7.04 million.
| Operating Cash Flow | -7.00M |
| Capital Expenditures | -38,000 |
| Depreciation & Amortization | 5,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.04M |
| FCF Per Share | -$2.45 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
